Wanbury Limited

WANBURY Stock View



Proj. ROE (%)
Proj. P/E (x)
Proj EV / EBITDA (x)
Proj. P/BV (x)
Proj. Revenue ( Cr.)

Stock View

Share on
The average score for Wanbury Limited stands at 5 against 6, three months back.

Wanbury Limited is a pharmaceutical company. The Company is engaged in the business of pharmaceutical and related activities, including research. The Company operates through two divisions: Active Pharmaceutical Ingredients (API) Business and Domestic Formulations Business. The Company through Active Pharmaceutical Ingredients (API) Business provides Metformin and Sertraline. Metformin is used for the treatment of type-1 diabetes and Sertraline is an anti-depressant. The Company through Domestic Formulations Business offers brands, which include Coriminic range, Chymonac range, Adtrol Range, Cusena, Rabiplus range, Nurture, Senasof, Nifty-SR and Zeva. The Company's subsidiaries include Wanbury Holding B.V., Wanbury Global FZE (UAE) and Ningxia Wanbury Fine Chemicals Co. Ltd. (China). It also provides Nurture-SF sugar-free protein supplements for Gestational diabetes mellitus (GDM) and Physicians (for diabetes/active lifestyle).

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
100 DMA ()
200 DMA ()
52 Weeks Range
Street View :-
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity